67 episodes
Shared genetic architecture and neurobiological pathways of problematic alcohol use and anxiety disorders
31/08/2026 | 7 mins.Problematic alcohol use frequently occurs in conjunction with anxiety disorders. Between 20 to 40 percent of individuals with anxiety disorders are also diagnosed with alcohol use disorder. Anxiety can lead people to use alcohol to self-medicate, and disordered alcohol use can cause increased anxiety for people when they go through withdrawal.
Joshua Gray is an associate professor in the department of psychology at Uniformed Services University, and one of the authors of a new study in the journal Neuropsychopharmacology. For the study, he and his colleagues drew on data from biobanks that originally included more than a million individuals. The samples were then modified to minimize overlap between the datasets, and the team ended up with about 860,000 individuals in the problematic alcohol use analysis and about 620,000 in the anxiety analysis.
Read the full study here: https://www.nature.com/articles/s41386-026-02494-z
Hosted on Acast. See acast.com/privacy for more information.Examining fronto-limbic brain and sleep mechanisms of antidepressant effects in cognitive-behavioral therapy for insomnia
02/07/2026 | 9 mins.Insomnia and depression are two serious and debilitating conditions. Insomnia on its own is linked to an increase in suicide risk, and insomnia can also exacerbate the severity of depression.
Andrea Goldstein-Piekarski, assistant professor in the department of psychiatry and behavioral sciences at Stanford, and Adam Krause, post-doctoral research fellow in Stanford’s psychiatry department, are two of the authors of a recent study in the journal Neuropsychopharmacology. Cognitive behavioral therapy for insomnia, or CBTI, is the gold standard for treating insomnia, and it’s been shown to relieve depressive symptoms as well.
Read the full study here: https://www.nature.com/articles/s41386-026-02431-0
Hosted on Acast. See acast.com/privacy for more information.Incentive salience, not psychomotor sensitization or tolerance, drives escalation of cocaine self-administration in heterogeneous stock rats
15/05/2026 | 9 mins.There are a number of theories that have been studied to try to explain addiction and drug use escalation, and thus to also create animal models of that behavior that can then serve to help develop treatments. One theory for escalation is that people feel worse and worse over time and so they take the drug to feel better. Another is that they just don’t get as much of a reaction to the drug and so need more and more of it to get the euphoria. And then there’s something called incentive salience, which is a craving for the drug.
Read the full study here: Incentive salience, not psychomotor sensitization or tolerance, drives escalation of cocaine self-administration in heterogeneous stock rats | Neuropsychopharmacology
Hosted on Acast. See acast.com/privacy for more information.Oxytocin neurons in the anterior and posterior paraventricular nucleus have distinct behavioral functions and electrophysiological profiles
23/02/2026 | 9 mins.Oxytocin has become known for having anti-anxiety and affiliative behavioral effects. That’s why clinicians and researchers are excited about using oxytocin as a potential therapeutic.
Brian Trainor is a professor at UC Davis, and his lab has been studying this complexity for the past decade. For an animal model, they work with a territorial, aggressive, monogamous rodent species called California mice. If the male is removed and the female is forced to defend their nest, she will experience what’s known as social defeat, and she will exhibit what’s called inhibited affiliative behavior, the type that can be affected by oxytocin — and this effect can be studied in a mouse’s brain.
Read the full study here: https://www.nature.com/articles/s41386-026-02352-y
Hosted on Acast. See acast.com/privacy for more information.- Cannabis, which is increasingly legally available, both for therapeutic and recreational use, is now one of the most commonly used drugs worldwide. Of people who have ever used cannabis, studies vary, but they estimate that about 10-25 percent of people who use cannabis go on to develop cannabis use disorder.
Uri Bright is a postdoctoral associate at the Yale School of Medicine and is one of the authors of a recent study in the journal Neuropsychopharmacology on the genetics of cannabis lifetime use — which is anyone who has ever used cannabis even once. That’s a distinct population from people who have cannabis use disorder, as his colleagues had looked into in the previous study.
Hosted on Acast. See acast.com/privacy for more information.
More Science podcasts
Trending Science podcasts
About NPP BrainPod
BrainPod is the podcast from the journal Neuropsychopharmacology, produced in association with Nature Publishing Group. Join us as we delve into the latest basic and clinical research that advance our understanding of the brain and behavior, featuring highlighted content from a top journal in fields of neuroscience, psychiatry, and pharmacology. For complete access to the original papers and reviews featured in this podcast, subscribe to Neuropsychopharmacology. Hosted on Acast. See acast.com/privacy for more information.
Podcast websiteListen to NPP BrainPod, StarTalk Radio and many other podcasts from around the world with the radio.net app

Get the free radio.net app
- Stations and podcasts to bookmark
- Stream via Wi-Fi or Bluetooth
- Supports Carplay & Android Auto
- Many other app features
Get the free radio.net app
- Stations and podcasts to bookmark
- Stream via Wi-Fi or Bluetooth
- Supports Carplay & Android Auto
- Many other app features


NPP BrainPod
Scan code,
download the app,
start listening.
download the app,
start listening.
NPP BrainPod: Podcasts in Family






































